FIT Testing: An Overview

被引：16
作者：
Lukejohn W. Day
Taft Bhuket
James Allison
机构：
[1] San Francisco General Hospital and Trauma Center,Division of Gastroenterology, Department of Medicine
[2] Alameda Health System,Division of Gastroenterology, Department of Medicine
[3] University of California,Division of Gastroenterology
[4] San Francisco,undefined
[5] Kaiser Permanente Northern California Division of Research,undefined
来源：
Current Gastroenterology Reports | 2013年 / 15卷 / 11期
关键词：
Fecal immunochemical testing; Colorectal cancer screening; Quality; Fecal occult blood;
D O I：
10.1007/s11894-013-0357-x
中图分类号：
学科分类号：
摘要：
Colorectal cancer (CRC) is a common, but preventable, disease and is the second most common cause of cancer-related deaths in the U.S. CRC screening has proven effective at reducing both the incidence and mortality of this disease, using any of a number of screening tests available. The test options range from the least invasive and least expensive to more invasive and costly options. Fecal occult blood testing is the oldest, least expensive, and least invasive of these options and has evolved from the poorly sensitive standard guaiac test to the newer and diagnostically superior fecal immunochemical test (FIT) for hemoglobin. This article explores the evolutionary history of fecal occult blood testing, examines test performance characteristics among different FOBTs, and evaluates the role of the FIT in programmatic CRC screening.
引用
收藏
相关论文
共 394 条
  • [61] MacLowry JD(2001)One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon N Engl J Med 345 555-60
  • [62] Barrows GH(2005)Colonoscopic screening of average-risk women for colorectal neoplasia N Engl J Med 352 2061-8
  • [63] Burton RM(2000)Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings N Engl J Med 343 169-74
  • [64] Jarrett DD(2010)Colorectal cancers detected after colonoscopy frequently result from missed lesions Clin Gastroenterol Hepatol 8 858-64
  • [65] Russell GG(2013)Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study Gastroenterology 144 74-80 e1
  • [66] Alford MD(2011)Complications of colonoscopy Gastrointest Endosc 74 745-52
  • [67] Songster CL(2013)Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies Am J Gastroenterol 108 120-32
  • [68] Songster CL(2011)Missed work related to mid-week screening colonoscopy Dig Dis Sci 56 2114-9
  • [69] Barrows GH(2007)Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy Gastrointest Endosc 65 648-56
  • [70] Jarrett DD(2008)Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study Med Decis Making 28 56-65
234567891011